Patents Assigned to JOINT STOCK COMPANY "PHARMASYNTEZ"
  • Publication number: 20140079663
    Abstract: The invention relates to inhibitory compounds of a p38 MAP kinase having a structure of type (I)-(VII) which can be used for the treatment or prophylaxis of adhesion. Pharmaceutical compositions are disclosed containing an effective amount of the substance SB203580 or one or more of the conjugated compounds of type (I)-(VII) or a combination thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient. Also disclosed is the use of the substance SB203580 as an agent having anti-adhesion activity. Also disclosed is a method for the prophylaxis and/or treatment of a disease or a condition in which there is a possibility of the formation and/or growth of adhesions, which makes it possible to dispense with the additional administration of a preparation in the post-operative period.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicant: Joint Stock Company "Pharmasyntez"
    Inventors: Mikhail Gennadievich Shurygin, Irina Aleksandrovna Shurygina
  • Publication number: 20130052265
    Abstract: This invention relates to the field of chemical-pharmaceutical industry, specifically a new tuberculosis treatment that contains, as an active ingredient, 4-thioureido-iminomethylpyridinium perchlorate at a therapeutically effective and safe level and pharmaceutically acceptable excipients. In addition, this treatment relates to a method of the preparation of the new drug, providing a high yield of the new treatment. The new treatment has a higher tuberculostatic activity (200 times as high) and lower toxicity (2.4 times as low), as compared to a prototype drug, and is stable during long-term storage. This medicament may be used for treating and preventing all forms of pulmonary and extrapulmonary TB by using the new treatment in combination with other TB drugs.
    Type: Application
    Filed: October 22, 2012
    Publication date: February 28, 2013
    Applicant: JOINT STOCK COMPANY "PHARMASYNTEZ"
    Inventor: Joint Stock Company "Pharmasyntez"